SWISS GRC
- Glenmark eyes pain management marketGlenmark Pharmaceuticals on Monday said its Swiss subsidiary has completed phase I clinical trials for GRC 6211, a pain reliever, and plans...28 May, 2007, 03.25 PM IST
Load More- Glenmark eyes pain management market